Cu-DSF also inhibited ALDH1 (Aldehyde Dehydrogenase 1), a potent anti-cancer target that can potentially sensitize cancer stem cells to traditional chemotherapeutic cancer drugs. Here, ALDH1A1 is linked to cancer.